Evidence-based medicine applied to cervical cancer

被引:4
作者
Kitchener, H [1 ]
机构
[1] St Marys Hosp, Acad Unit Obstet & Gynaecol, Manchester M13 0JH, Lancs, England
关键词
cervical cancer; randomized controlled trials; evidence-based medicine; Cochrane Institute;
D O I
10.1016/S0168-1702(02)00186-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
All too frequently current healthcare is characterised by non evidence based practice, variation in practice, inadequate outcome data, inequality of access to optimal treatment and ultimately a lack of evidence base. By developing a culture of evidence based medicine some of these shortcomings could be addressed. In trying to develop a true assessment of evidence, we have to confront a huge literature, much of which does not inform clinical effectiveness which is a key underpinning of an evidence base. It is necessary to adopt methodologically sound protocols as well as a systematic approach to weighing the evidence. In general informative studies should specify the population studied, the intervention, with what it is being compared, and relevant clinical outcomes. It is clear that randomised controlled trials (RCTs) will carry most weight in terms of reducing outcome bias. The Cochrane Collaboration is an international collaboration dedicated to the science of systematic reviews and meta analysis. It functions through a process of peer review of Title of Review, Proposed Protocol, Completed Review with eventual publication in the electronic Cochrane Library. There is an active Cochrane Collaborative Review Group in Gynaecological Cancer. As far as evidence for the effective management of cervical cancer is concerned, the strongest evidence would relate to the effectiveness of concurrent chemoradiation for treating locally advanced disease compared with radiation alone. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 5 条
  • [1] Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
    Keys, HM
    Bundy, BN
    Stehman, FB
    Muderspach, LI
    Chafe, WE
    Suggs, CL
    Walker, JL
    Gersell, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15) : 1154 - 1161
  • [2] Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer
    Landoni, F
    Maneo, A
    Colombo, A
    Placa, F
    Milani, R
    Perego, P
    Favini, G
    Ferri, L
    Mangioni, C
    [J]. LANCET, 1997, 350 (9077) : 535 - 540
  • [3] Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
    Morris, M
    Eifel, PJ
    Lu, JD
    Grigsby, PW
    Levenback, C
    Stevens, RE
    Rotman, M
    Gershenson, DM
    Mutch, DG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15) : 1137 - 1143
  • [4] Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
    Peters, WA
    Liu, PY
    Barrett, RJ
    Stock, RJ
    Monk, BJ
    Berek, JS
    Souhami, L
    Grigsby, P
    Gordon, W
    Alberts, DS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) : 1606 - 1613
  • [5] Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
    Rose, PG
    Bundy, BN
    Watkins, EB
    Thigpen, JT
    Deppe, G
    Maiman, MA
    Clarke-Pearson, DL
    Insalaco, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15) : 1144 - 1153